Testo-200 Dosage

Prior to initiating testosterone cypionate, confirm the diagnosis of hypogonadism by ensuring that serum testosterone concentrations have been measured in the morning on at least two separate days and that lhese serum testoslerone concentrations are below lhe normal range.
Testosterone cypionate injection is for intramuscular use only.
It should not bo given intravonously. Intramuscular injections should bo given deep in the gluteal muscle.
The suggested dosage for testosterone cypionate injection varies depending on the age, sex, and diagnosis of the individual patient Dosage is adjusted according to the patient's response and the appearance of adverse reactions.
Various dosage regimens have been used to induce pubertal changes in hypogonadal males; some experts have advocated lower dosages initially, gradually increasing the dose as puberty progresses, with or without a decrease to maintenance levels. Other experts emphasize that higher dosages are needed lo induce pubertal changes and lower dosages can be used for maintenance after puberty. The chronological and skeletal ages must be taken into consideration, both in determining the initial dose and in adjusting the dose.
For replacement in the hypogonadal male, 50 to 400 mg should be administered every two to four weeks.
Parenteral drug producls should be inspected visually for particulate rnatter and discoloration prior to administration, whenever solution and container permit. Warming and shaking the vial should redissolve any crystals that may have formed during storage at temperatures lower than recommended. Crystals does not usually occur when stored properly. Presentation:
Testosterone Cypionate lnjeclion. USP, 200 mg/ml is a clear, pale yellow oleaginous viscous, sterile solution intended for intramuscular administration available as:
10 ml Vial, 2000mgl 10ml, 200mg/ml